All articles tagged with #global funding
The article warns that cuts in global aid, particularly to malaria programs, threaten to cause a resurgence of malaria in Africa, potentially adding nearly a million deaths by 2030, with environmental changes and drug resistance exacerbating the crisis.
The WHO recommends the use of the long-acting HIV prevention injection lenacapavir, approved in the US for twice-yearly use, as part of global efforts to combat HIV, especially in high-risk groups. Despite its potential, funding cuts, particularly from the US, threaten to undermine HIV prevention programs worldwide, risking increased infections and deaths. Gilead Sciences has committed to supplying lenacapavir at no profit to improve access in low-income countries, but global resource gaps remain a major challenge in ending the HIV epidemic.
Antibiotic resistance is a growing concern as more bacteria become resistant to the drugs developed to treat infections. Overexposure to antibiotics, misuse by patients, and their presence in the food chain contribute to the development of resistance. In 2019, 1.27 million people died from antibiotic-resistant bacterial infections worldwide. Funding for research and development of new antibiotics is declining, posing a threat to future medical treatments. Finding alternative medications to combat resistant bacteria is crucial, but requires increased global funding and innovative solutions.